Delphia Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 21-50 Employees

Delphia Therapeutics revenue & valuation

Annual revenue	$2,481,095
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$8,000,000
Total funding	$67,000,000

Key Contacts at Delphia Therapeutics

Tori Frank

Associate Director, Program Management

Jill Parolin

Director, Human Resources

Michael Burke

Sr. Director, Chemistry

Brendan Veeneman

Director, Computational Biology

Klaus Michelsen

Director, Biophysics

Eric T. Larson

Director Of Structural Biology And Protein Science

Tamara D. Hopkins

Director, Medicinal Chemistry

Joseph Manna

Director, Head Of Dmpk

Joshua Sacher

Associate Director, Computational Chemistry

Matthew Niederst

Senior Director

Company overview

Headquarters	One Kendall Sq, Bldg. 200, Ste. 001, Cambridge, Massachusetts 02139, US
Websites	delphiatx.com 1abmedia.com
NAICS	541714
Employees	21-50
Socials

Delphia Therapeutics Email Formats

Delphia Therapeutics uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@delphiatx.com), used 46.4% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@delphiatx.com	46.4%
{first name}.{last name}	john.doe@delphiatx.com	46.4%
{first initial}	j@delphiatx.com	3.6%
{last name}	doe@delphiatx.com	3.6%

About Delphia Therapeutics

Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Senior

Entry

Employees by Department

Delphia Therapeutics has 13 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Delphia Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-02	4	$67,000,000

Funding Insights

$67,000,000

Total funding amount

$67,000,000

Most recent funding amount

Number of funding rounds

Delphia Therapeutics Tech Stack

Discover the technologies and tools that power Delphia Therapeutics's digital infrastructure, from frameworks to analytics platforms.

WP Rocket

Caching

lit-element

JavaScript libraries

lit-html

JavaScript libraries

Zendesk

Documentation

Cloudflare

CDN

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Lenis

JavaScript libraries

Three.js

JavaScript graphics

Yoast SEO

SEO

Frequently asked questions

Delphia Therapeutics is located in Cambridge, Massachusetts, US.

Delphia Therapeutics generates an estimated annual revenue of $2,481,095. This revenue figure reflects the company's market position and business performance in its industry.

Delphia Therapeutics has an estimated valuation of $8,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Delphia Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Delphia Therapeutics has raised a total of $67,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Delphia Therapeutics

Tori Frank

Associate Director, Program Management

Jill Parolin

Director, Human Resources

Michael Burke

Sr. Director, Chemistry

Brendan Veeneman

Director, Computational Biology

Klaus Michelsen

Director, Biophysics

Eric T. Larson